Trouver des Événements près de chez vous

Événements

Oct
19
  1.   Supply chain and logistics
  2.    Événement de groupe
  1.   19 Oct 2020 à 16:00 - 30 Avr 2022 à 16:00 - Europe/Stockholm
The Visibility for Vaccines (ViVa) platform is a stock visibility dashboard that visualizes the pipeline of current stocks, vaccine orders as well as forecasts. It enables country governments to bette…
The Visibility for Vaccines (ViVa) platform is a stock visibility dashboard that visualizes the pipeline of current stocks, vaccine orders as well as forecasts. It enables country governments to better identify and prevent potential vaccine stock outs or overstocks before they occur. The platform was developed by UNICEF, with funding from the UPS Foundation, and first introduced in 2016. ViVa currently has over 350 registered users in 37 countries.
This new course trains users on the functionalities of the ViVa platform, how to effectively analyze and interpret ViVa’s dashboards and data, as well as on how to integrate this analysis into routine business processes in countries. By adopting this comprehensive approach, the training aims to both strengthen Viva user competencies as well as promote a more data-based approach to vaccine supply decision-making.
The main target audience for this course are national government EPI staff. UNICEF country and regional staff, as well as other in-country vaccine partners, will also benefit from this course.
 
The training is availble on the Agora training website and is available in French and English.

 

You can access the course through the following links: 
English: https://agora.unicef.org/course/view.php?id=25034
French: https://agora.unicef.org/course/view.php?id=25803
 
 
Oct
18
  1.   Programme management
  2.    Public
  1.   18 Oct 2021 à 16:00 - 17:30 - Europe/Zurich
Webinar on novel oral polio vaccine type 2 (nOPV2) rollout – next steps Monday 18 October 2021  10h00 – 11h30 New York; 15h00 – 16h30 Brazzaville; 16h00 – 17h30 Geneva; 17h00 – 18h30 …

Webinar on novel oral polio vaccine type 2 (nOPV2) rollout – next steps

Monday 18 October 2021 

10h00 – 11h30 New York; 15h00 – 16h30 Brazzaville; 16h00 – 17h30 Geneva; 17h00 – 18h30 Amman/Nairobi; 19h30 – 21h00 New Delhi; 

22h00 – 23h30 Manila 

Join GPEI colleagues for a webinar to learn more about next steps for novel oral polio vaccine type 2 (nOPV2) rollout. Presenters will discuss topics including safety, genetic stability and clinical data to date, latest SAGE developments regarding nOPV2 use, use requirements going forward, and supply and prioritization. The presentation will be followed by a live Q&A session.  

This webinar will be for internal GPEI audiences, and will be available live in English, Arabic and French. GPEI regional teams are encouraged to invite country-level staff as appropriate.

--------------------------------------------------------------------------------------------------------------------------------------

Details: 

You are invited to a Zoom webinar.

When: Oct 18, 2021 07:00 AM Pacific Time (US and Canada)

Topic: Novel oral polio vaccine type 2 (nOPV2) rollout - next steps

Please click the link below to join the webinar:

https://gatesfoundation.zoom.us/j/98140499665?pwd=K3FybHFCRVgwR3RDSjRHa3FSWEVLUT09

Passcode: 298536

Or One tap mobile : 

US: +12532158782,,98140499665#,,,,*298536#  or +16699006833,,98140499665#,,,,*298536# 

Or Telephone:

Dial(for higher quality, dial a number based on your current location):

US: +1 253 215 8782  or +1 669 900 6833  or +1 346 248 7799  or +1 646 558 8656  or +1 301 715 8592  or +1 312 626 6799  or 888 475 4499 (Toll Free) or 833 548 0276 (Toll Free) or 833 548 0282 (Toll Free) or 877 853 5257 (Toll Free)

Webinar ID: 981 4049 9665

Passcode: 298536

International numbers available: https://gatesfoundation.zoom.us/u/apNUjotm6

Or an H.323/SIP room system:

    H.323: 

    162.255.37.11 (US West)

    162.255.36.11 (US East)

    115.114.131.7 (India Mumbai)

    115.114.115.7 (India Hyderabad)

    213.19.144.110 (Amsterdam Netherlands)

    213.244.140.110 (Germany)

    103.122.166.55 (Australia Sydney)

    103.122.167.55 (Australia Melbourne)

    149.137.40.110 (Singapore)

    64.211.144.160 (Brazil)

    149.137.68.253 (Mexico)

    69.174.57.160 (Canada Toronto)

    65.39.152.160 (Canada Vancouver)

    207.226.132.110 (Japan Tokyo)

    149.137.24.110 (Japan Osaka)

    Meeting ID: 981 4049 9665

    Passcode: 298536

    SIP: 98140499665@zoomcrc.com

    Passcode: 298536

If you have any questions about the webinar or experience any technical difficulties during the event, please reach out to Zulaa Sainjargal (sainjargala@who.int) or Samantha Ritter (samantha.ritter@gatesfoundation.org) or Emily Wright (emily.wright@gatesfoundation.org). 

Oct
20
  1.   Programme management
  2.    Public
  1.   20 Oct 2021 à 12:00 - 13:00 - Europe/Zurich
Webinar series: WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines The WHO’s Department of Immunization, Vaccines and Biologicals (IVB) and WHO Health Emergency programme (…

Webinar series: WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines

The WHO’s Department of Immunization, Vaccines and Biologicals (IVB) and WHO Health Emergency programme (WHE) are partnering with Project ECHO of the University of New Mexico (UNM), UNICEF, and TechNet-21 to host a series of 15 sessions that align with countries’ immediate and medium-term needs.
 

Topic of this session: Operational Microplanning for COVID-19 Vaccination and experience with multiple products

TheNational Deployment and Vaccination Plans(NDVPs) guidance provided the framework for over 100 countries to develop their national strategies. At the district and sub-district levels, successful introduction, uptake and equitable distribution of COVID-19 vaccines depend on robust and continuously funded operational microplanning. While planning at subnational levels, factors to consider include: erratic, restricted and unpredictable vaccine availability; use of multiple vaccine products with different characteristics; the size of populations and their diversity; and the over-stressed and resource-constrained health system. To support governments, WHO has developed tools and guidance to strategically plan for COVID-19 vaccine deployment at the national level towards maximizing reach while addressing the challenges. The guidance provides a conceptual framework, and guidance on the process for COVID-19 vaccination microplanning at the district/sub-district level and its catchment areas.

  

When: Wednesday 20 October 12:00 CEST

Registration link: https://echo.zoom.us/webinar/register/WN_-laAatzPS1SeSxvJmF-PNg

 

Interpretation into French and Spanish will be available

Mai
09
  1.   Global initiatives
  2.    Public
  1.   9 Mai 2022 - 22 Mai 2022 - UTC
ADVAC is a two-week training programme for decision-makers, including academia, industry, governmental and non-governmental agencies. The Course aims to facilitate critical decision-making in vaccino…

ADVAC is a two-week training programme for decision-makers, including academia, industry, governmental and non-governmental

agencies. The Course aims to facilitate critical decision-making in vaccinology by providing participants with a comprehensive

overview of the various aspects of vaccinology (immunology, vaccine development, clinical trials, regulatory processes,

vaccine-specific issues including new vaccines, vaccination strategies and policies, programme implementation, humanitarian

emergencies, social, economic, political and ethical issues, financing, and communications…)

Registration for the course will open on the website (www.advac.org) on July 1, 2021 and will close on November 15, 2021

There is no event available on the site. Be the first to create it today!
Unable to load tooltip content.